Literature DB >> 21209113

Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef.

Richard D Sloan1, Björn D Kuhl, Daniel A Donahue, André Roland, Tamara Bar-Magen, Mark A Wainberg.   

Abstract

Although transcription from unintegrated human immunodeficiency virus type 1 (HIV-1) DNA can occur inside infected cells, yielding all classes of viral mRNA transcripts, the translation of viral proteins is very limited. One of the proteins made is Nef, but it is unclear whether Nef produced in this way is able to play a role in immune evasion as occurs with integrated virus. We therefore asked whether transcription from preintegrated HIV-1 cDNAs could result in Nef-mediated modulation of cell surface major histocompatibility complex class I (MHC-I) expression. We infected a Rev-CEM green fluorescent protein (GFP) reporter cell line with virus and blocked integration though use of either an inactive integrase or the integrase inhibitor raltegravir. Infected cells were assayed by flow cytometry for cell surface expression of the HLA-A, HLA-B, and HLA-C allotypes (HLA-ABC), HLA-A31, and HLA-E. Viral RNA and DNA products were assayed via quantitative PCR (qPCR). The prevention of integration had no effect, relative to productively infected cells, on levels of expression of multiply spliced viral mRNA transcripts and Nef protein. Downregulation of HLA-ABC and HLA-A31 also occurred at levels similar to those seen in cells in which integration had occurred. Parallel experiments assaying cell surface HLA-ABC expression in infected activated primary CD4(+) T cells produced a similar pattern of results. Hence, the capacity of HIV-1 to modulate MHC-I is not linked to its ability to integrate. Thus, Nef-mediated evasion of host immune responsiveness might be attributable, in part at least, to transcription from unintegrated viral DNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21209113      PMCID: PMC3067938          DOI: 10.1128/JVI.01854-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression.

Authors:  G S Ogg; S Kostense; M R Klein; S Jurriaans; D Hamann; A J McMichael; F Miedema
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

3.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Nef expressed from human immunodeficiency virus type 1 extrachromosomal DNA downregulates CD4 on primary CD4+ T lymphocytes: implications for integrase inhibitors.

Authors:  Laura Gillim-Ross; Andrea Cara; Mary E Klotman
Journal:  J Gen Virol       Date:  2005-03       Impact factor: 3.891

6.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Authors:  K L Collins; B K Chen; S A Kalams; B D Walker; D Baltimore
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

7.  Phenotypic analysis of antigen-specific T lymphocytes.

Authors:  J D Altman; P A Moss; P J Goulder; D H Barouch; M G McHeyzer-Williams; J I Bell; A J McMichael; M M Davis
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

8.  Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1.

Authors:  W B Dyer; G S Ogg; M A Demoitie; X Jin; A F Geczy; S L Rowland-Jones; A J McMichael; D F Nixon; J S Sullivan
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; S K Arya; R C Gallo; P Lusso
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

10.  HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells.

Authors:  Jacob Nattermann; Hans Dieter Nischalke; Valesko Hofmeister; Bernd Kupfer; Golo Ahlenstiel; Georg Feldmann; Jiirgen Rockstroh; Elisabeth H Weiss; Tilman Sauerbruch; Ulrich Spengler
Journal:  Antivir Ther       Date:  2005
View more
  12 in total

1.  Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.

Authors:  Szu-Han Huang; Yanqin Ren; Allison S Thomas; Dora Chan; Stefanie Mueller; Adam R Ward; Shabnum Patel; Catherine M Bollard; Conrad Russell Cruz; Sara Karandish; Ronald Truong; Amanda B Macedo; Alberto Bosque; Colin Kovacs; Erika Benko; Alicja Piechocka-Trocha; Hing Wong; Emily Jeng; Douglas F Nixon; Ya-Chi Ho; Robert F Siliciano; Bruce D Walker; R Brad Jones
Journal:  J Clin Invest       Date:  2018-01-22       Impact factor: 14.808

2.  Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.

Authors:  Beatrix Meltzer; Deemah Dabbagh; Jia Guo; Fatah Kashanchi; Mudit Tyagi; Yuntao Wu
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

Review 3.  From promoting to inhibiting: diverse roles of helicases in HIV-1 Replication.

Authors:  Rene-Pierre Lorgeoux; Fei Guo; Chen Liang
Journal:  Retrovirology       Date:  2012-09-28       Impact factor: 4.602

4.  Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA.

Authors:  Nkiruka Emeagwali; James E K Hildreth
Journal:  Virol J       Date:  2012-11-19       Impact factor: 4.099

Review 5.  The role of unintegrated DNA in HIV infection.

Authors:  Richard D Sloan; Mark A Wainberg
Journal:  Retrovirology       Date:  2011-07-01       Impact factor: 4.602

Review 6.  Different Pathways Leading to Integrase Inhibitors Resistance.

Authors:  Eloïse Thierry; Eric Deprez; Olivier Delelis
Journal:  Front Microbiol       Date:  2017-01-11       Impact factor: 5.640

7.  Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.

Authors:  Fei Yi; Jia Guo; Deemah Dabbagh; Mark Spear; Sijia He; Kylene Kehn-Hall; Jacque Fontenot; Yan Yin; Mathieu Bibian; Chul Min Park; Ke Zheng; Ha Jeung Park; Veronica Soloveva; Dima Gharaibeh; Cary Retterer; Rouzbeh Zamani; Margaret L Pitt; John Naughton; Yongjun Jiang; Hong Shang; Ramin M Hakami; Binhua Ling; John A T Young; Sina Bavari; Xuehua Xu; Yangbo Feng; Yuntao Wu
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

8.  IFITM proteins inhibit HIV-1 protein synthesis.

Authors:  Wing-Yiu Jason Lee; Rebecca Menhua Fu; Chen Liang; Richard D Sloan
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

Review 9.  HIV-1 persistence in the CNS: Mechanisms of latency, pathogenesis and an update on eradication strategies.

Authors:  Shilpa Sonti; Adhikarimayum Lakhikumar Sharma; Mudit Tyagi
Journal:  Virus Res       Date:  2021-07-24       Impact factor: 3.303

10.  Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle.

Authors:  Soundasse Munir; Sylvain Thierry; Frédéric Subra; Eric Deprez; Olivier Delelis
Journal:  Retrovirology       Date:  2013-08-13       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.